These observations show the capacity of A2AR activation to also prevent hepatic IRI in the presence of steatosis and enlighten a novel survival circuit that is implicated in the hepatoprotective action of A2aR: the PI3K/Akt-induced prevention of the cytotoxic ASK1/JNK signaling. The gene discussed is MAP3K5; the disease is steatosis.